Wird geladen...
Modified mRNA as a new therapeutic option for pediatric respiratory diseases and hemoglobinopathies
BACKGROUND: The immunogenicity and limited stability of conventional messenger RNA (mRNA) has traditionally restricted its potential therapeutic use. In 1992, the first clinical application of mRNA was reported as a potential protein-replacement therapy; however, subsequent investigations have not b...
Gespeichert in:
| Veröffentlicht in: | Mol Cell Pediatr |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer Berlin Heidelberg
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4654728/ https://ncbi.nlm.nih.gov/pubmed/26589812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40348-015-0022-6 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|